1. Zoetis - Top 10 animal health companies

Zoetis ($ZTS)
2013 Revenue: $4.56 billion
HQ: Florham Park, NJ

Zoetis started out life as an independent animal health company as the largest player in the mix with a market share of about 20%. It was spun off from Pfizer ($PFE) in early 2013 as part of Pfizer CEO Ian Read's slim-down moves. Because it was not independent in 2012, financial comparisons are a bit tricky, but it reported operational revenue growth of 7% and adjusted net income growth of 32%, outpacing the market. Zoetis generated 42% of its revenue in the U.S. and 24% in Europe. Its two largest categories are cattle and companion animals, which generated 36% each. Anti-infectives at 29% and vaccines at 26% together made up just over half of all of its sales. The company launched a number of new products last year, including getting FDA approval for Apoquel, a nonsteroidal treatment for itching in dogs. CEO Juan Ramón Alaix said the treatment is expected to grow fast and could contribute 1% of the company's revenues this year. -- Eric Palmer (email | Twitter)

For more:
FDA asks Lilly, Zoetis to help it thwart antibiotic resistance
Pfizer's Zoetis spinoff outshines drug biz, at least for a day

1. Zoetis - Top 10 animal health companies

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…